Antibody specificity and related clinical features in antiphospholipid syndrome.

about

Antibody specificity and related clinical features in antiphospholipid syndrome.

Item

http://www.wikidata.org/entity/Q47702901

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Antibody specificity and related clinical features in antiphospholipid syndrome.

@en

Antibody specificity and related clinical features in antiphospholipid syndrome.

@nl

type

Item

label

Antibody specificity and related clinical features in antiphospholipid syndrome.

@en

Antibody specificity and related clinical features in antiphospholipid syndrome.

@nl

prefLabel

Antibody specificity and related clinical features in antiphospholipid syndrome.

@en

Antibody specificity and related clinical features in antiphospholipid syndrome.

@nl

P1476

Antibody specificity and related clinical features in antiphospholipid syndrome.

@en

P2093

J Kaburaki

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls

The 1982 revised criteria for the classification of systemic lupus erythematosus

Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

Obstetric management of antiphospholipid syndrome.

P304

113-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/S101650170021

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24383686

http://www.w3.org/2001/XMLSchema#string